rs199543866
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001413023.1(RECQL4):c.-764C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00115 in 1,612,326 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001413023.1 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000775 AC: 118AN: 152268Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000604 AC: 149AN: 246720Hom.: 0 AF XY: 0.000572 AC XY: 77AN XY: 134654
GnomAD4 exome AF: 0.00119 AC: 1735AN: 1460058Hom.: 0 Cov.: 31 AF XY: 0.00112 AC XY: 810AN XY: 726302
GnomAD4 genome AF: 0.000775 AC: 118AN: 152268Hom.: 0 Cov.: 34 AF XY: 0.000632 AC XY: 47AN XY: 74386
ClinVar
Submissions by phenotype
not provided Uncertain:4
Identified without a second RECQL4 variant in a patient with clinical features of Rothmund-Thomson syndrome and with a missense RECQL4 variant in a patient with complex craniosynostosis (PMID: 12734318, 32139749); Observed heterozygous in a patient with sporadic pancreatic cancer and with a second RECQL4 variant in a patient with osteosarcoma (PMID: 32659497, 32191290); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30680959, 32139749, 32659497, 37731390, 35591945, 12734318, 32191290) -
- -
- -
- -
Baller-Gerold syndrome Uncertain:1Benign:1
- -
- -
not specified Uncertain:1
DNA sequence analysis of the RECQL4 gene demonstrated a sequence change, c.308C>T, in exon 4 that results in an amino acid change, p.Pro103Leu. This sequence change has been previously described in an individual with RECQL4-related disorder (PMID: 12734318). This sequence change has been described in the gnomAD database with a low frequency of 0.11% in the non-Finnish European subpopulation (dbSNP rs199543866). The p.Pro103Leu change affects a poorly conserved amino acid residue of the RECQL4 protein. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD) provide contradictory results for the p.Pro103Leu substitution. Due to insufficient evidence and the lack of functional studies, the clinical significance of the p.Pro103Leu change remains unknown at this time. -
Inborn genetic diseases Uncertain:1
The c.308C>T (p.P103L) alteration is located in exon 4 (coding exon 4) of the RECQL4 gene. This alteration results from a C to T substitution at nucleotide position 308, causing the proline (P) at amino acid position 103 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Rothmund-Thomson syndrome type 2 Uncertain:1
The RECQL4 c.308C>T (p.Pro103Leu) missense change has a maximum subpopulation frequency of 0.12% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In silico tools predict a benign effect of this variant on protein function, but to our knowledge these predictions have not been confirmed by functional assays. This variant has been reported in an individual meeting diagnostic criteria for Rothmund-Thomson syndrome who did not have a second pathogenic variant in RECQL4 identified (PMID: 12734318). In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Hereditary cancer-predisposing syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at